BIB Ultra Nasdaq Biotechnology Proshares
- 50.660
- +0.430+0.86%
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Takeda-backed Ascentage Pharma Files for $100M IPO
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Weekly Buzz: So far, Santa is Letting us Down
Looking At Amgen's Recent Unusual Options Activity
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Daiichi Sankyo Gets Japanese Approval for Datroway
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
10 Health Care Stocks With Whale Alerts In Today's Session
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
ProShares Ultra Nasdaq Biotechnology Declares Quarterly Distribution of $0.3964
Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions
How Is The Market Feeling About Alnylam Pharmaceuticals?
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Spotlight on Amgen: Analyzing the Surge in Options Activity
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
2024's Top and Bottom Nasdaq-100 Performers Includes NVDA, APP, INTC, MRNA, and More
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today